Investors

Presentation

This section provides all the information and documents of interest to the financial community.

Shareholders’ space

Scientific
01/12/2026

A major new scientific publication on TOTUM-448

Download
Corporate
01/08/2026

Valbiotis announces an exclusive distribution agreement in the Middle East

Download
Corporate
12/18/2025

Valbiotis recognized by the 2025 Top Santé Award for Valbiotis Plus® Serenity

Download
Scientific
12/08/2025

Valbiotis announces completion of recruitment for the Cardio-Liver clinical study conducted (TOTUM•448)

Download

Breakdown of share capital

Capital breakdown updated as of November, 27, 2025
62% of capital held by individual investors (Source: TPI, November, 27, 2025)

Financial calendar

 

Events
3
March 2025

Publication of Annual Financial Report

18
April 2025

Annual General Meeting

2
March 2026

Publication of annual results

Regulatory information

Access documents

Annual general meetings

Access documents

Financial information

 

Analysts coverage

Portzamparc*
Analysts: Mohamed Kaabouni

Invest Securities*
Analyst: Thibaut Voglimacci-Stephanopoli

TP ICAP Midcap*
Analyst: Corentin Marty

*Sponsored research